A tribal nation is likely to succeed in blocking Kalshi from offering sports contracts on its land, a federal judge said in what appears to be the first ruling of its kind against the prediction market operator. The Ho-Chunk Nation, a federally recognized Native American tribe, can move ahead with its lawsuit accusing the company of violating the Indian Gaming Regulatory Act, or IGRA, and has show...
A tribal nation is likely to succeed in blocking Kalshi from offering sports contracts on its land, a federal judge said in what appears to be the first ruling of its kind against the prediction market operator. The Ho-Chunk Nation, a federally recognized Native American tribe, can move ahead with its lawsuit accusing the company of violating the Indian Gaming Regulatory Act, or IGRA, and has shown “a likelihood of success” in its complaint, US District Judge William M. Conley in Madison, Wisconsin, wrote in a ruling Monday. The dispute centers on whether sports-related event contracts are gaming that can be regulated by states’ laws and federal tribal law, or financial instruments that fall under federal oversight. In a fast-moving nationwide legal fight , Kalshi has had mixed results arguing that it should be overseen by the Commodity Futures Trading Commission rather than state officials. Conley’s decision marks a rare victory for a Native American tribe pressing claims against Kalshi under IGRA. A similar showdown is pending at a federal appeals court in California, where several tribes failed to win an injunction they sought in a lower court. Earlier this year, several tribes sought to support Tennessee’s efforts to regulate Kalshi but a judge rejected their request to file a friend-of-the-court brief. The company went on to win a preliminary injunction blocking enforcement by Tennessee officials. In Wisconsin, Conley faulted Kalshi’s interpretation of the tribe’s IGRA-required Tribal-State compact with regulators as “without basis in the text, legislative history or common sense.” Kalshi’s reading of the compact would have only allowed tribal nations and states to sue each other, rather than third parties. Still, Conley denied the Ho-Chunk Nation’s request for a preliminary injunction against Kalshi because the tribe did not show “irreparable harm” if the company continued operating its exchange on a tribal tract of about 17 square miles while the court fight ...
Earnings Call Insights: ZoomInfo Technologies Inc. (GTM) Q1 2026 Management View "We started 2026 by delivering revenue and adjusted operating income above the high end of our Q1 guidance." (CEO Henry Schuck) "As macro conditions worsened at the end of the quarter, we experienced a regression in our downmarket and upmarket growth trajectories." (CEO Schuck) "In the closing days of March and into A...
Earnings Call Insights: ZoomInfo Technologies Inc. (GTM) Q1 2026 Management View "We started 2026 by delivering revenue and adjusted operating income above the high end of our Q1 guidance." (CEO Henry Schuck) "As macro conditions worsened at the end of the quarter, we experienced a regression in our downmarket and upmarket growth trajectories." (CEO Schuck) "In the closing days of March and into April, we saw a trend of AI and agentic confusion in our customer conversations... This led to a pause in purchasing decisions and our software customers were particularly affected." (CEO Schuck) "As a result, we are revising our full year guidance down in conjunction with significant cost reductions that we believe will position us with structurally higher operating margins and create a faster path back to durable growth." (CEO Schuck) "Beginning in Q3, customers will have the flexibility to convert historical per seat spend into consumption across ZoomInfo data, insights, applications and agents." (CEO Schuck) "In Q1, Salesforce released its prospecting agent with ZoomInfo as the first and primary external data provider." (CEO Schuck) "Q1 GAAP revenue was $310 million... adjusted operating income was $110 million... Unlevered free cash flow was $120 million." (CFO Michael O'Brien) "The changes announced today impact 20% of our employees or 600 team members, including closing our facilities in Israel." (CFO O'Brien) Outlook Q2 non-GAAP net income guidance of $0.26 to $0.28 per share vs. $0.27 (analysts estimates); Q2 revenue guidance of $300 million to $303 million vs. $309,767,870 (analysts estimates). "For the full year 2026, we now expect GAAP revenue in the range of $1.185 billion to $1.205 billion" and "adjusted operating income in the range of $437 million to $447 million." (CFO O'Brien) "We plan to roll out a hybrid pricing model later in Q3 that pairs a low annual platform fee with prepurchase credits rather than our traditional seat-based packages." (CFO O'Brien) "...
Earnings Call Insights: Kyntra Bio (KYNB) Q1 2026 Management View CEO Thane Wettig said the quarter’s focus remained on “consistent progress we have made across our portfolio,” highlighting “FG-3246, our potential first-in-class antibody drug conjugate targeting CD46 and its companion PET imaging agent in metastatic castration-resistant prostate cancer” and “roxadustat, our potential treatment for...
Earnings Call Insights: Kyntra Bio (KYNB) Q1 2026 Management View CEO Thane Wettig said the quarter’s focus remained on “consistent progress we have made across our portfolio,” highlighting “FG-3246, our potential first-in-class antibody drug conjugate targeting CD46 and its companion PET imaging agent in metastatic castration-resistant prostate cancer” and “roxadustat, our potential treatment for anemia due to lower-risk myelodysplastic syndromes.” CEO Wettig stated the Phase II monotherapy study for FG-3246 and FG-3180 in the “post-ARPI pre-chemo setting” was “actively enrolling patients at multiple sites in the U.S. with an anticipated interim analysis in the fourth quarter of 2026,” and added, “We now have 21 sites activated in top-tier institutions across the U.S.” CEO Wettig said roxadustat is “advancing as planned,” and added, “We recently received constructive feedback from the FDA on the Phase III design and are in the process of finalizing the protocol,” while reiterating, “we expect to initiate the Phase III trial in the second half of 2026.” CFO David DeLucia said, “For the first quarter of 2026, total revenue was $3.7 million,” and added, “As of March 31, we reported $100.3 million in cash, cash equivalents, investments and accounts receivable” and “expect the company to have cash runway into 2028.” Outlook CEO Wettig reiterated timing catalysts, saying the company expects “interim analysis from the Phase II monotherapy trial in the fourth quarter of 2026” and “initiation of the Phase III trial for roxadustat in lower-risk MDS in the second half of 2026.” CEO Wettig framed the Phase II interim bar as oriented toward continuing to mature rPFS, saying, “we've got a hurdle that is consistent with this composite response of ORR and PSA 50 that we saw in the Phase I monotherapy trial,” and added, “we are most interested in getting to the more fully mature rPFS data in 2027.” Compared with Q4 2025, management’s interim-readout language shifted from “the secon...
Construction machines are still roving around Ford Motor Co. ’s new factory in Marshall, Michigan, but their work is almost done — and it’s a scene to warm President Donald Trump’s heart. An iconic US company is poised to cut the ribbon on its first wholly owned domestic greenfield plant in half a century, and bring manufacturing jobs and money to a slice of small-town America that’s been starved ...
Construction machines are still roving around Ford Motor Co. ’s new factory in Marshall, Michigan, but their work is almost done — and it’s a scene to warm President Donald Trump’s heart. An iconic US company is poised to cut the ribbon on its first wholly owned domestic greenfield plant in half a century, and bring manufacturing jobs and money to a slice of small-town America that’s been starved of both. The twist in the tale: All this comes with a big assist from China, where Trump is headed this week to meet his counterpart Xi Jinping. For its $3 billion BlueOval Battery Park Michigan, Ford linked up with Contemporary Amperex Technology Co. Ltd. , or CATL, the Chinese behemoth that leads the world in battery tech. Antagonism between the superpowers has made this kind of partnership increasingly rare — and controversial enough to draw flak, from the streets of Marshall to the halls of Congress . The plant got built anyway. On a sunny April afternoon, crews were installing a few last bits of equipment, and prepping parking lots for some 1,700 employees who are slated to start production of electric-vehicle batteries within months. One possible question for Trump and Xi, at their May 14-15 summit in Beijing, is whether this collaboration could be a blueprint for more. The two leaders have much else to discuss, from tariff rates to America’s attack on Iran and the energy crisis it’s caused. Still, Chinese investment in the US, which has slowed to a trickle since Trump’s first term, has been a key background issue in previous talks . Beijing pushed last year for a rollback of national-security restrictions on Chinese deals in the US — floating the potential for the kind of big-dollar capital flows that Trump likes to tout in his second term, worth as much as $1 trillion. But there’s little sign of progress since then on a mooted investment board. For Chinese firms, the hurdles are especially high in the auto sector, where US manufacturers worry they’ll be unable to co...
K-pop superstar G-Dragon’s decision to gift his long-serving staff members flats worth a combined total of hundreds of millions of won (around several hundred thousand USD) has sparked a frenzy among netizens, with some asking, “Are you still hiring?” Dubbed the “King of K-pop,” the 38-year-old singer Kwon Ji-yong, better known as G-Dragon in the entertainment industry, is one of the most popular ...
K-pop superstar G-Dragon’s decision to gift his long-serving staff members flats worth a combined total of hundreds of millions of won (around several hundred thousand USD) has sparked a frenzy among netizens, with some asking, “Are you still hiring?” Dubbed the “King of K-pop,” the 38-year-old singer Kwon Ji-yong, better known as G-Dragon in the entertainment industry, is one of the most popular stars in South Korea and across Asia. He is the leader of BigBang, one of the world’s bestselling...
Renowned biologist Xu Xianzhong has returned to China, taking up a full-time position in the southern tech hub of Shenzhen, months after four researchers in his laboratory at the University of Michigan were accused by the United States of “biological material smuggling”. Xu, a fellow of the prestigious American Association for the Advancement of Science – has joined the Shenzhen Medical Academy of...
Renowned biologist Xu Xianzhong has returned to China, taking up a full-time position in the southern tech hub of Shenzhen, months after four researchers in his laboratory at the University of Michigan were accused by the United States of “biological material smuggling”. Xu, a fellow of the prestigious American Association for the Advancement of Science – has joined the Shenzhen Medical Academy of Research and Translation (SMART) as a senior investigator with its Institute of Bio-Architecture...
(RTTNews) - The China stock market rebounded on Monday, one session after ending the four-day winning streak in which it had advanced more than 100 points or 2.5 percent. The Shanghai Composite Index now sits just above the 4,225-point plateau and it's expected to open in the gre
(RTTNews) - The China stock market rebounded on Monday, one session after ending the four-day winning streak in which it had advanced more than 100 points or 2.5 percent. The Shanghai Composite Index now sits just above the 4,225-point plateau and it's expected to open in the gre
Cameron Hamilton led FEMA briefly in 2025. He was removed by the Trump administration after telling Congress that the agency should continue to exist. Now, he's been nominated to lead it once again. (Image credit: Jose Luis Magana)
Cameron Hamilton led FEMA briefly in 2025. He was removed by the Trump administration after telling Congress that the agency should continue to exist. Now, he's been nominated to lead it once again. (Image credit: Jose Luis Magana)